Advanced in Reticulohistiocytoma
Advanced in Reticulohistiocytoma
1275 York Ave, 
New York, NY 

Overview

Christopher Forlenza is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Forlenza is rated as an Advanced provider by MediFind in the treatment of Reticulohistiocytoma. His top areas of expertise are Hodgkin Lymphoma, Langerhans Cell Histiocytosis, Histiocytosis, Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 20 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 13 clinical trials in the study of Reticulohistiocytoma.

Specialties
Pediatric Hematology Oncology
Licenses
Student in an Organized Health Care Education/Training Program in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Health First
  • HMO
  • POS
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

1275 York Ave, New York, NY 10065

Additional Areas of Focus

Dr. Forlenza has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


20 Clinical Trials

A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
View 19 Less Clinical Trials
Similar Doctors
Distinguished in Reticulohistiocytoma
Pediatric Hematology Oncology
Distinguished in Reticulohistiocytoma
Pediatric Hematology Oncology
1275 York Ave, 
New York, NY 
 (0.1 miles away)
Languages Spoken:
English

Ira Dunkel is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Dunkel is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. His top areas of expertise are Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Brain Stem Cancer.

Distinguished in Reticulohistiocytoma
Pediatric Hematology Oncology
Distinguished in Reticulohistiocytoma
Pediatric Hematology Oncology
211 Clinton St, Apt 2c, 
Brooklyn, NY 
 (5.6 miles away)
Languages Spoken:
English

Nitya Gulati is a Pediatric Hematologist Oncology provider in Brooklyn, New York. Dr. Gulati is rated as an Advanced provider by MediFind in the treatment of Reticulohistiocytoma. Her top areas of expertise are Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, and Non-Langerhans-Cell Histiocytosis.

Advanced in Reticulohistiocytoma
Pediatric Hematology Oncology
Advanced in Reticulohistiocytoma
Pediatric Hematology Oncology
40 Sunshine Cottage Rd, Munger Pavilion, Room 110, 
Valhalla, NY 
 (23.5 miles away)
Languages Spoken:
English

Nader El is a Pediatric Hematologist Oncology provider in Valhalla, New York. Dr. El is rated as an Advanced provider by MediFind in the treatment of Reticulohistiocytoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Langerhans Cell Histiocytosis, Reticulohistiocytoma, and Histiocytosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Forlenza's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile